Clinical trial
Efficacy of the "Consilium" Smartphone App for Detecting Symptoms and Treatment Side Effects in Cancer Patients Depending on Form of Medication Application, Age and Outpatient Characteristics: Observational Study
NCT03578731 is registered in ClinicalTrials.gov with OnkoZentrum Zürich AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of the "Consilium" Smartphone App for Detecting Symptoms and Treatment Side Effects in Cancer Patients Depending on Form of Medication Application, Age and Outpatient Characteristics: Observational Study
- Lead sponsor
- OnkoZentrum Zürich AG
- Phase
- Observational
- Overall status
- Terminated
- Start date
- March 5, 2018
- Completion date
- October 10, 2020
- Enrollment
- 224 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.
ehealth, telemedicine